Interestingly, Ma et al. declared that, when using mouse models of colorectal cancer, low-dose naltrexone (an opioid antagonist) decreased proliferation and promoted the apoptosis of cancer cells with increased TNF-α expression [149]. Here, TNF is linked to colorectal cancer.